Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The schizophrenic spectrum: an epidemiological viewpoint].

J Angst1, C Scharfetter

  • 1Psychiatrische Universitätsklinik Zürich, Schweiz. jangst@bli.unizh.ch

Fortschritte Der Neurologie-Psychiatrie
|September 5, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The relationship between attention deficit hyperactivity disorder, bipolarity and mixed features in major depressive patients: Evidence from the BRIDGE-II-Mix Study.

Journal of affective disorders·2019
Same author

Bipolar spectrum in major depressive disorders.

European archives of psychiatry and clinical neuroscience·2018
Same author

Aggressiveness in depression: a neglected symptom possibly associated with bipolarity and mixed features.

Acta psychiatrica Scandinavica·2017
Same author

Hypomania Checklist-32 - cross-validation of shorter versions screening for bipolar disorders in an epidemiological study.

Acta psychiatrica Scandinavica·2017
Same author

Difficulties of diagnosing mood disorders correctly.

Acta psychiatrica Scandinavica·2017
Same author

Screening for bipolar disorders: A public health issue.

Journal of affective disorders·2016
Same journal

[Rare hereditary and acquired diseases with parkinson's syndrome].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Digital transformation in multiple sclerosis: Advances in diagnostics, monitoring and patient-centred care].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Dementia with Lewy bodies].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Impact of the PEPP reimbursement system and other developments on inpatient care of general psychiatry patients 2005 to 2022: a retrospective analysis].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[The pathology of the brain eating amoeba Naegleria fowleri].

Fortschritte der Neurologie-Psychiatrie·2026
Same journal

[Chronic vestibular syndromes: Correct diagnosis and treatment].

Fortschritte der Neurologie-Psychiatrie·2026
See all related articles

Recognizing early signs of schizophrenia spectrum disorders is crucial for prevention. Research suggests a dimensional approach to these conditions, rather than distinct categories, is more accurate.

Area of Science:

  • Epidemiology
  • Psychiatry

Context:

  • The boundary between health and illness is not always clear, particularly within the schizophrenia spectrum.
  • Sub-clinical syndromes, including personality disorders and traits, are more common in the general population than schizophrenia itself.
  • Early identification of at-risk and mild cases is vital for effective prophylaxis.

Purpose:

  • To highlight the need for improved diagnostic instruments with validated predictive power for the schizophrenia spectrum.
  • To advocate for epidemiological research focusing on the entire schizophrenia spectrum.
  • To support a dimensional model of mental health traits and syndromes.

Summary:

  • The schizophrenia spectrum includes sub-clinical syndromes more prevalent than diagnosed schizophrenia.

Related Experiment Videos

  • Current diagnostic tools lack sufficient prospective validation for early risk identification.
  • Epidemiological research should embrace a dimensional view of schizophrenia spectrum traits.

    • Impact:

    • Future research may confirm a dimensional distribution of traits and syndromes, challenging categorical models.
    • Findings can provide evidence against the discrimination and stigmatization of patients with schizophrenia spectrum disorders.
    • Enhanced understanding can improve early recognition and prophylaxis strategies.